agree cpap's growth spurt will slow and oral devices will start taking some of that market .
and to think resmed which is one of the leaders in cpap has a market cap approaching $5 billion dollars. so you can see what potential growth is yet to come for somnomed who is still in its initial global roll out phase, sure minor hicups will occurr whilst introducing the product to unknown markets but for a market cap of $17m it sure has long term growth appeal.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
65.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $140.4M | |||
| Open | High | Low | Value | Volume |
| 65.0¢ | 65.0¢ | 65.0¢ | $3.866K | 5.947K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10001 | 65.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.5¢ | 8764 | 1 |
View Market Depth
| Last trade - 12.42pm 16/07/2025 (20 minute delay) ? |
| SOM (ASX) Chart |